Gluva Health connects CGM wellness outcomes to employer health plan claims data — giving self-funded employers meaningful, documented evidence that their wellness investment is working.
Three steps from employer claims data to documented stop-loss renewal impact — no wellness theater, no engagement metrics, no guesswork.
Gluva Health analyzes your TPA claims extract and PBM drug utilization data to identify employees with pre-diabetic indicators, metabolic pharmacy spend, and GLP-1 exposure — before they cost your plan more. Risk identification is driven entirely by actual claims data, not voluntary screening or health fairs.
High-risk employees receive a continuous glucose monitor and personalized dietitian sessions anchored to their actual glucose data — not generic nutrition advice. Interventions concentrate on employees with the highest room for measurable improvement, making every dollar of program spend count.
After one plan year, Gluva Health pulls an updated claims extract and compares participant glucose improvements against plan cost trends — documenting measurable reductions in metabolic claims spend that support more favorable stop-loss underwriting.
ROI documentation requires completed TPA data integration and a minimum multi-year program commitment. Results will vary based on employer plan design, cohort risk profile, and intervention adherence.
The Gluva Health employer dashboard is in active development. The preview below illustrates the reporting capabilities being built — showing the claims-linked ROI documentation available once fully integrated with your TPA.
Every savings assumption traces to a named peer-reviewed study and a documented methodology. No projections without citations.
Kuo et al. — N=5,948 employees with prediabetes in employer-sponsored health plans. $4,552 in direct medical savings per enrollee over 2 years. 88% probability program was cost-saving. 2.8pp absolute diabetes risk reduction.
Aetna retrospective analysis — N=7,336 patients. CGM initiation associated with −31% all-cause hospitalizations, −67% diabetes-related admissions, and −40% diabetes-related ED visits. All findings p<0.0001.
Parker et al. — Average annual cost per diagnosed diabetes patient: $22,540. People with diabetes have medical expenditures 2.6× higher. GLP-1 therapy adds $18,000–$30,000+ per member per year at commercial plan rates.
2,000 to 30,000 covered lives. You bear 100% of your plan's claims cost. Gluva Health gives your CFO the documented ROI framework that justifies the wellness budget and supports cost trajectory reduction.
Differentiate your practice with a wellness program designed to produce claims-linked ROI documentation at every renewal. Early broker partners have input on platform features and preferred client onboarding.
Gluva Health's claims-linked outcomes methodology provides underwriters with meaningful data on risk reduction in the employer's highest-cost cohort — supporting more informed renewal conversations.
Gluva Health's standard claims extract format works with any TPA. One data authorization from the employer plan sponsor produces the baseline needed to identify high-risk employees and document outcomes.
Gluva Health is accepting expressions of interest from self-funded employers, brokers, and TPA partners ahead of our official launch. Early partners have direct input on platform development and preferred onboarding access.
First adopter employers receive preferred pricing and co-authorship rights on case study outcomes
Direct input on dashboard features, report format, and TPA integration priorities
Eligible employers may participate in the Northwestern University IRB-approved study
Expressing interest starts a conversation — no commitment required to learn more
We'll be in touch within 2 business days to schedule an introductory call.
We've received your expression of interest and will be in touch within 2 business days to schedule an introductory call.
In the meantime, feel free to email us directly at rich@selffund.com